Great Luck News on October 31st | American pharmaceutical company Amgen (AMGN.USA) rose more than 1.5%, closing at $320.4. On the news front, Amgen's Q3 revenue was $8.5 billion, market expectation was $8.52 billion; adjusted earnings per share were $5.58, market expectation was $5.1. The company expects full-year revenue to be between $33 billion and $33.8 billion, previously forecasted $32.8 billion to $33.8 billion; adjusted EPS is expected to be between $19.2 and $20, previously forecasted $19.1 to $20.1. (Great Luck News)
美股异动|安进涨超1.5% Q3调整后每股收益超过预期
US stock movement | Amgen rose more than 1.5%, Q3 adjusted earnings per share exceeded expectations.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.